Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000644

Director sold 43,202 shares at an average $16.90 ($730,125)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-28 Sale : show line 1 in the form −31,592 $17.04 $538,328 2,456,419 I
2017-06-29 Sale : show line 2 in the form −11,610 $16.52 $191,797 2,444,809 I
Open-market sales · 43,202 sh · avg $16.90 · $730,125
Loading xslF345X03/vonemster_form4jun282017.xml…